Position statement


Coronavirus vaccination programme - statement

On 2 December 2020, the Medicines and Healthcare products Regulatory Agency (MHRA) authorised the Pfizer-BioNTech vaccine for those aged 16 years and over in the UK under an emergency use authorisation. On 30 December MHRA issued an emergency use authorisation for the AstraZeneca vaccine. Advice fro...

Vaccination in the UK - position statement

Vaccination is proven to be a highly effective intervention to prevent disease, and in the UK vaccines are routinely offered against 18 infections in childhood and adolescence, resulting in a substantial saving in morbidity and mortality. We provide key facts and considerations, our recommendations ...